{"product_id":"ccnb2-antibody-sc-f2047","title":"Cyclin B2\/CCNB2 Antibody","description":"\u003ch2\u003eAbout the Target\u003c\/h2\u003e\u003cp\u003eCCNB2 is a target of interest in many antibody-based workflows. The cell cycle is fundamental to cellular biological processes. In mammals, there are three B-type cyclins: Cyclin B1, Cyclin B2, and Cyclin B3. Cyclin B3 associates with CDK2, whereas Cyclin B1 and Cyclin B2 associate with CDK1. Depending on the literature source, CCNB2 may also be discussed as Cyclin B2\/CCNB2.\u003c\/p\u003e\u003cp\u003eReported cellular context includes centrosome, cytoplasm, cytosol, and membrane, which can matter when signal is compared across treatments or changing cell states. Following CCNB2 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.\u003c\/p\u003e\u003ch2\u003eResearch Context\u003c\/h2\u003e\u003cp\u003eCCNB2 is commonly interpreted in the context of cancer and cell cycle research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans centrosome, cytoplasm, and cytosol, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.\u003c\/p\u003e\u003cp\u003eConsider these angles when interpreting target-level changes:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eapparent redistribution between centrosome, cytoplasm, and cytosol across matched conditions\u003c\/li\u003e\n\u003cli\u003echanges associated with proliferative state, oncogenic signaling, or treatment response\u003c\/li\u003e\n\u003cli\u003ecell-cycle linked differences in abundance, timing, or compartmental enrichment\u003c\/li\u003e\n\u003cli\u003eco-patterning with orthogonal markers and control conditions that clarify pathway state\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eVariant Considerations\u003c\/h2\u003e\u003cp\u003eIf your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for CCNB2. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.\u003c\/p\u003e\u003cp\u003eStandardize sampling time, control choice, and downstream analysis thresholds so apparent differences in CCNB2 reflect biology rather than handling. When interpreting CCNB2, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.\u003c\/p\u003e\u003cp\u003eFor multi-run studies, a shared reference condition can keep CCNB2 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.\u003c\/p\u003e","brand":"Selleck Chemicals","offers":[{"title":"20 µl","offer_id":57577852830041,"sku":"F2047-20UL","price":199.0,"currency_code":"EUR","in_stock":true},{"title":"100 µl","offer_id":57577852862809,"sku":"F2047-100UL","price":489.0,"currency_code":"EUR","in_stock":true},{"title":"2 × 100 µl","offer_id":57577852895577,"sku":"F2047-2X100UL","price":729.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0923\/1011\/0553\/files\/F2047-IHC1.jpg?v=1773600140","url":"https:\/\/absource-diagnostics.myshopify.com\/products\/ccnb2-antibody-sc-f2047","provider":"Absource Diagnostics","version":"1.0","type":"link"}